Skip to main content
Trending storyContinuously updated

MucoLife Therapeutics wins €91K Vinnova grant for COPD drug manufacturing

1 reports1 report sources3 hours agoUpdate

Get up to speed on this story

AI Summary

MucoLife Therapeutics received a €91,000 (SEK 1 million) grant from Sweden's innovation agency Vinnova to set up scalable manufacturing for MLT-001, its COPD treatment candidate. The award comes through Vinnova's call supporting small and medium-sized companies' use of life science infrastructure. The process work will be done closely with a contract development and manufacturing organization partner, aiming for a process that reaches a suitable purity level at a documented yield, the company said.

AI-generated from reports · 2 hours agoUpdate

Latest updatesNov 6 21:58
MucoLife Therapeutics Secures €91K from Vinnova to Scale Manufacturing of COPD Treatment MLT-001

Report timeline

Follow the reports to understand different sides of the story.

Nov 6
  1. Tech.eu
    MucoLife Therapeutics Secures €91K from Vinnova to Scale Manufacturing of COPD Treatment MLT-001

    MucoLife Therapeutics received €91,000 (SEK 1 million) from Sweden's Vinnova to establish scalable manufacturing of MLT-001.

Trend for this story

Not enough continuous observation data yet; trend chart is not drawn for now.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing